CN219340219U

CN219340219U - Improved CD3 receptor agonist kit

Info

Publication number: CN219340219U
Application number: CN202320736279.4U
Authority: CN
Inventors: 黄启宽; 朱国振; 彭祥翔
Original assignee: Shanghai Jinghan Biotechnology Co ltd
Current assignee: Shanghai Jinghan Biotechnology Co ltd
Priority date: 2023-04-06
Filing date: 2023-04-06
Publication date: 2023-07-14
Anticipated expiration: 2033-04-06

Abstract

The utility model belongs to the technical field of kits, and particularly relates to an improved CD3 receptor agonist kit, which comprises a box body, wherein a box cover is movably arranged at the top of the box body, a plurality of sealing plugs are arranged on the inner wall of the top of the box cover, a plugboard is fixedly arranged on the box cover, a locking seat is fixedly arranged on the front surface of the box body, two sliding grooves are formed in the inner walls of two sides of the box body, sliding blocks are movably arranged in the two sliding grooves, and a first spring is fixedly arranged at the top of each sliding block.

Description

Improved CD3 receptor agonist kit

Technical Field

The utility model relates to the technical field of kits, in particular to an improved CD3 receptor agonist kit.

Background

The receptor agonist is a drug which can be combined with a receptor and make the receptor excited so as to show corresponding physiological effects or drug actions, and is characterized by stronger affinity and intrinsic activity, can exert maximum drug effects through receptor excitation and needs to be placed in a kit for inspection before the receptor agonist is put into use.

However, in the existing equipment, the reagent kit only comprises a reagent placement hole, and the placement hole is in contact with the reagent, so that in order to ensure the detection accuracy, the reagent kit is directly abandoned after each inspection, and can be used once, so that the cost is high, and the improved CD3 receptor agonist reagent kit is provided.

Disclosure of Invention

The utility model aims to solve the defects in the prior art and provides an improved CD3 receptor agonist kit.

In order to achieve the above purpose, the present utility model adopts the following technical scheme: the utility model provides an improvement formula CD3 acceptor agonist kit, includes the box body, the top activity of box body is equipped with the lid, be equipped with a plurality of sealing plugs on the top inner wall of lid, fixedly on the lid be equipped with the picture peg, the front of box body is fixed and is equipped with the locking seat, two spouts have all been seted up on the both sides inner wall of box body, two sets of all move about in the spout are equipped with the slider, every the top of slider is all fixed and is equipped with first spring, the top of first spring with the top fixed connection of spout, four fixed be equipped with same place the seat between the slider, the top of placing the seat is equipped with a plurality of holes of placing, the both sides of placing the hole all are equipped with the mounting groove, every all be equipped with the clamping structure in the mounting groove, be equipped with extrusion structure in the box body.

As a further description of the above technical solution:

the clamping structure comprises a connecting rod movably connected with one side inner wall of the mounting groove, one end of the connecting rod penetrates through one side inner wall of the mounting groove and extends into the placing hole, a clamping plate is fixedly arranged at one end of the connecting rod, a second spring is fixedly arranged at one end of the connecting rod, which is far away from the clamping plate, one end of the second spring, which is far away from the connecting rod, is fixedly connected with one side inner wall of the mounting groove, a vertical plate is fixedly arranged at the top of the connecting rod, and a pulling block is fixedly arranged at the top of the vertical plate.

As a further description of the above technical solution:

the clamping plate is arc-shaped, an anti-slip pad is fixedly arranged on one side, far away from the connecting rod, of the clamping plate, and the anti-slip pad is made of silica gel.

As a further description of the above technical solution:

the mounting groove is characterized in that a through hole is formed in one side inner wall of the mounting groove, a sealing ring is arranged on the inner wall of the through hole, and the inner wall of the sealing ring is attached to the connecting rod.

As a further description of the above technical solution:

the extrusion structure comprises a rotating rod movably connected with inner walls on two sides of a box body, one end of the rotating rod penetrates through one side inner wall of the box body and extends out of the box body, a rotating handle is fixedly arranged at one end of the rotating rod, a pin rod is movably arranged on the rotating handle, a mounting block is fixedly arranged on the rotating rod, and a push rod is fixedly arranged on the mounting block.

As a further description of the above technical solution:

through grooves are formed in the inner walls of the two sides of the box body, bearings are arranged in the through grooves, the outer ring of each bearing is fixedly connected with the inner wall of the through groove, and the inner ring of each bearing is fixedly sleeved on the rotating rod.

The utility model has the following beneficial effects:

1. compared with the prior art, this improvement formula CD3 acceptor agonist kit through setting up place seat, place parts such as hole, grip block, connecting rod, second spring and slipmat, can be with reagent leading-in test tube, then place the test tube in placing the hole again, grip block, connecting rod and second spring's cooperation each other can realize the location to the test tube, after reagent detects, directly take out the test tube cleaning disinfection or change can, the kit can multiple use, has reduced detection cost.

2. Compared with the prior art, this improvement formula CD3 acceptor agonist kit through setting up parts such as a plurality of sealing plugs, bull stick, installation piece, ejector pin, turning handle and round pin pole, closes the lid after the test tube is placed, and turns the turning handle, and the turning handle drives the bull stick, and the bull stick drives installation piece and ejector pin again, and the ejector pin extrusion is placed the seat and is made it and shift up, after placing the seat and remove to the top dead center, sealing plug and test tube mouth laminating have realized the sealing to the test tube, place the condition that the test tube appears leaning on the transportation.

Drawings

FIG. 1 is a schematic diagram showing the perspective structure of a modified CD3 receptor agonist kit according to the present utility model;

FIG. 2 is a schematic illustration of the front cross-sectional structure of a modified CD3 receptor agonist kit according to the present utility model;

FIG. 3 is a schematic perspective view of an extrusion configuration of an improved CD3 receptor agonist kit according to the present utility model;

fig. 4 is a schematic perspective view of a clamping structure in a modified CD3 receptor agonist kit according to the present utility model.

Legend description:

1. a case body; 2. a box cover; 3. a sealing plug; 4. inserting plate; 5. a locking seat; 6. a chute; 7. a slide block; 8. a first spring; 9. a placement seat; 10. placing the hole; 11. a mounting groove; 12. a clamping structure; 121. a connecting rod; 122. a second spring; 123. a clamping plate; 124. an anti-slip pad; 125. a riser; 126. pulling blocks; 13. an extrusion structure; 131. a rotating rod; 132. a mounting block; 133. a push rod; 134. a rotating handle; 135. and a pin rod.

Detailed Description

The following description of the embodiments of the present utility model will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present utility model, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the utility model without making any inventive effort, are intended to be within the scope of the utility model.

Referring to fig. 1 to 4, the present utility model provides an improved CD3 receptor agonist kit: comprises a box body 1, wherein the top of the box body 1 is hinged with a box cover 2, the top inner wall of the box cover 2 is provided with a plurality of sealing plugs 3, the sealing plugs 3 can block a test tube port to prevent reagents from spilling, a plugboard 4 is welded on the box cover 2, the front bolt of the box body 1 is provided with a locking seat 5, two sliding grooves 6 are respectively arranged on the inner walls of two sides of the box body 1, sliding blocks 7 are respectively and slidably arranged in the two groups of sliding grooves 6, the top of each sliding block 7 is respectively welded with a first spring 8, the top of each first spring 8 is welded with the top of each sliding groove 6, the same placing seat 9 is welded between the four sliding blocks 7, the top of each placing seat 9 is provided with a plurality of placing holes 10, each placing hole 10 is used for accommodating test tubes filled with reagents, two sides of each placing hole 10 are respectively provided with a mounting groove 11, each mounting groove 11 is internally provided with a clamping structure 12, each clamping structure 12 comprises a connecting rod 121 which is slidably arranged on the inner wall of one side of the mounting groove 11, the through hole is formed in one side inner wall of the mounting groove 11, the sealing ring is arranged on the inner wall of the through hole, the inner wall of the sealing ring is attached to the connecting rod 121, one end of the connecting rod 121 penetrates through one side inner wall of the mounting groove 11 and extends into the placing hole 10, the clamping plate 123 is welded at one end of the connecting rod 121, the clamping plate 123 is arc-shaped, an anti-slip pad 124 is adhered to one side of the clamping plate 123, which is far away from the connecting rod 121, and is made of silica gel, the friction force between the anti-slip pad 124 and a test tube can be improved, a second spring 122 is welded at one end of the connecting rod 121, which is far away from the clamping plate 123, and one side inner wall of the mounting groove 11 is welded at one end of the second spring 122, a vertical plate 125 is welded at the top of the connecting rod 121, a pull block 126 is installed on a top bolt of the vertical plate 125, and the clamping structure 12 is arranged, so that the test tube can be positioned;

be equipped with extrusion structure 13 in box body 1, extrusion structure 13 includes the bull stick 131 of rotating the installation with box body 1 both sides inner wall, all be equipped with logical groove on the both sides inner wall of box body 1, all be equipped with the bearing in two logical grooves, bearing outer lane and logical inslot wall welding, the fixed cover of bearing inner race is established on bull stick 131, one end of bull stick 131 runs through one side inner wall of box body 1 and extends to outside box body 1, and the one end welding of bull stick 131 has rotating handle 134, insert on rotating handle 134 and be equipped with round pin pole 135, the welding has installation piece 132 on the bull stick 131, the welding has ejector pin 133 on the installation piece 132, extrusion structure 13's setting can be with upwards jack-up of placing seat 9, make place seat 9 drive the test tube and reciprocate, finally, laminate the top and the sealing plug 3 of test tube, realize sealing function.

Working principle: when in use, firstly, the reagent to be monitored is led into the test tube, then two pull blocks 126 at two sides of the placing hole 10 are pulled in opposite directions away from each other, the pull blocks 126 drive the vertical plates 125, the vertical plates 125 drive the connecting rods 121, the two connecting rods 121 drive the two clamping plates 123 to pull in opposite directions away from each other, the clamping plates 123 drive the anti-slip pads 124, then the test tube with the reagent is placed between the two anti-slip pads 124, the top of the test tube is slightly lower than the top plane of the placing hole 10, then the pull blocks 126 are loosened simultaneously, the rebound force of the second springs 122 is received, the two connecting rods 121 are close to each other, the two clamping plates 123 and the anti-slip pads 124 are driven to be close to each other, when the anti-slip pads 124 are attached to the outer wall of the test tube, namely, the test tube is fixed, then the box cover 2 is closed, the plug board 4 is inserted into the locking seat 5, at the moment, the sealing plugs 3 are positioned right above the placing holes 10, then the pin rod 135 is pulled out, the rotating handle 134 is rotated ninety degrees, the rotating handle 134 drives the rotating rod 131, the rotating rod 131 drives the two mounting blocks 132 and the ejector rod 133, the ejector rod 133 extrudes the placing seat 9 at the top, the placing seat 9 moves upwards and drives the test tubes to move upwards, when the rotating rod 131 rotates to ninety degrees, the placing seat 9 reaches the top dead center, at the moment, the sealing plugs 3 are attached to the flat mouths of the test tubes to seal the test tubes, and then the pin rod 135 penetrates through the positioning holes on the rotating handle 134 and is inserted into the positioning holes on one side of the box body 1 to position the rotating handle 134 and the rotating rod 131.

Finally, it should be noted that: the foregoing description is only illustrative of the preferred embodiments of the present utility model, and although the present utility model has been described in detail with reference to the foregoing embodiments, it will be apparent to those skilled in the art that modifications may be made to the embodiments described, or equivalents may be substituted for elements thereof, and any modifications, equivalents, improvements or changes may be made without departing from the spirit and principles of the present utility model.

Claims

1. An improved CD3 receptor agonist kit comprising a housing (1), characterized in that: the top activity of box body (1) is equipped with lid (2), be equipped with a plurality of sealing plugs (3) on the top inner wall of lid (2), fixed picture peg (4) being equipped with on lid (2), the front of box body (1) is fixed and is equipped with locking seat (5), two spouts (6) have all been seted up on the both sides inner wall of box body (1), two sets of all move about in spout (6) are equipped with slider (7), every the top of slider (7) is all fixed and is equipped with first spring (8), the top of first spring (8) with the top fixed connection of spout (6), four fixed be equipped with same place seat (9) between slider (7), the top of place seat (9) is equipped with a plurality of place hole (10), the both sides of place hole (10) all are equipped with mounting groove (11), every all be equipped with clamping structure (12) in mounting groove (11), be equipped with extrusion structure (13) in box body (1).

2. The modified CD3 receptor agonist kit of claim 1, wherein: the utility model discloses a clamping structure (12) is including connecting rod (121) with mounting groove (11) one side inner wall swing joint, one end of connecting rod (121) runs through one side inner wall of mounting groove (11) and extends to in placing hole (10), just the fixed grip block (123) that is equipped with in one end of connecting rod (121), one end that grip block (123) was kept away from to connecting rod (121) is fixed to be equipped with second spring (122), one end that connecting rod (121) was kept away from to second spring (122) with one side inner wall fixed connection of mounting groove (11), the top of connecting rod (121) is fixed and is equipped with riser (125), the top of riser (125) is fixed and is equipped with pull block (126).

3. The modified CD3 receptor agonist kit of claim 2, which is characterized by: the clamping plate (123) is arc-shaped, an anti-slip pad (124) is fixedly arranged on one side, far away from the connecting rod (121), of the clamping plate (123), and the anti-slip pad (124) is made of silica gel.

4. The modified CD3 receptor agonist kit of claim 2, which is characterized by: a through hole is formed in the inner wall of one side of the mounting groove (11), a sealing ring is arranged on the inner wall of the through hole, and the inner wall of the sealing ring is attached to the connecting rod (121).

5. The modified CD3 receptor agonist kit of claim 1, wherein: the extrusion structure (13) comprises a rotating rod (131) movably connected with inner walls of two sides of the box body (1), one end of the rotating rod (131) penetrates through one side inner wall of the box body (1) and extends out of the box body (1), one end of the rotating rod (131) is fixedly provided with a rotating handle (134), a pin rod (135) is movably arranged on the rotating handle (134), a mounting block (132) is fixedly arranged on the rotating rod (131), and a push rod (133) is fixedly arranged on the mounting block (132).

6. The modified CD3 receptor agonist kit of claim 5, wherein: the box body (1) is characterized in that through grooves are formed in the inner walls of two sides of the box body (1), bearings are arranged in the through grooves, an outer ring of each bearing is fixedly connected with the inner walls of the through grooves, and an inner ring of each bearing is fixedly sleeved on the rotating rod (131).